Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation

doi:10.4254/wjh.v14.i4.729

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4007)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

209

WORD

HTML

2526

Figures (1-6)

216

Tables (1-1)

162

Sum=3200

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

297

Download

510

Sum=807

Apr 27, 2022 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Apr 27, 2022; 14(4): 729-743
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.729

Full Size Figure Download Figure

Figure 1 Structure of baicalin.

Citation: Ganguly R, Kumar R, Pandey AK. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J Hepatol 2022; 14(4): 729-743
URL: https://www.wjgnet.com/1948-5182/full/v14/i4/729.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i4.729